Premarket Biotech Digest – Teva, MannKind, Quidel, Applied DNA Sciences Reported Earnings
May 12, 2017 at 06:40 AM EDT
Teva Pharmaceutical Industries announced its first quarter results. Applied DNA Sciences reported its second quarter loss at $3.4 million.